READY IN CASE RUBBING ALCHL 50 PCT WNTRGRN 16 FLOZ distributed to specific Family Dollar Stores 0...

FDA Drug Recall #D-1390-2022 — Class II — June 23, 2022

Recall Summary

Recall Number D-1390-2022
Classification Class II — Moderate risk
Date Initiated June 23, 2022
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Family Dollar Stores, Llc.
Location Chesapeake, VA
Product Type Drugs
Quantity Unknown

Product Description

READY IN CASE RUBBING ALCHL 50 PCT WNTRGRN 16 FLOZ distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.

Reason for Recall

CGMP Deviations: product held outside appropriate storage temperature conditions.

Distribution Pattern

Nationwide within the United States

Lot / Code Information

SKU:900535

Other Recalls from Family Dollar Stores, Llc.

Recall # Classification Product Date
D-0566-2023 Class II Advil Liqui-Gels Solubilized Ibuprofen Capsules... Mar 31, 2023
D-0563-2023 Class II Advil Ibuprofen Tablets, 200 mg Pain Reliever/F... Mar 31, 2023
D-0565-2023 Class II Advil Dual Action with Acetaminophen Acetaminop... Mar 31, 2023
D-0564-2023 Class II Advil Ibuprofen Tablets, 200 mg Pain Reliever/F... Mar 31, 2023
D-1470-2022 Class II Colgate Whitening Mouthwash, OPTIC WHITE ICY FR... Aug 10, 2022

Frequently Asked Questions

cGMP stands for Current Good Manufacturing Practice — the FDA's regulations governing drug manufacturing quality. A cGMP recall means the company failed to follow required manufacturing standards. This could involve inadequate testing, poor environmental controls, documentation failures, or process deviations. cGMP recalls do not always mean the product is directly harmful — in many cases, quality records are insufficient to confirm the product meets specifications. However, the FDA requires a recall because without proper documentation, product quality cannot be assured. These are often Class II or Class III recalls.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.